- Home
- SCNI vs LTRY Comparison
SCNI vs LTRY Comparison
Compare SCNI & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- LTRY
- Stock Information
- Founded
- SCNI 2003
- LTRY 2015
- Country
- SCNI Israel
- LTRY United States
- Employees
- SCNI N/A
- LTRY N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- LTRY Computer Software: Prepackaged Software
- Sector
- SCNI Health Care
- LTRY Technology
- Exchange
- SCNI Nasdaq
- LTRY Nasdaq
- Market Cap
- SCNI 3.1M
- LTRY 3.2M
- IPO Year
- SCNI N/A
- LTRY N/A
- Fundamental
- Price
- SCNI $3.51
- LTRY $0.37
- Analyst Decision
- SCNI
- LTRY
- Analyst Count
- SCNI 0
- LTRY 0
- Target Price
- SCNI N/A
- LTRY N/A
- AVG Volume (30 Days)
- SCNI 8.1K
- LTRY 1.1M
- Earning Date
- SCNI 11-22-2024
- LTRY 12-16-2024
- Dividend Yield
- SCNI N/A
- LTRY N/A
- EPS Growth
- SCNI N/A
- LTRY N/A
- EPS
- SCNI 8.20
- LTRY N/A
- Revenue
- SCNI $452,000.00
- LTRY $6,143,350.00
- Revenue This Year
- SCNI N/A
- LTRY N/A
- Revenue Next Year
- SCNI N/A
- LTRY N/A
- P/E Ratio
- SCNI $0.43
- LTRY N/A
- Revenue Growth
- SCNI N/A
- LTRY 190.77
- 52 Week Low
- SCNI $2.23
- LTRY $0.22
- 52 Week High
- SCNI $8.92
- LTRY $3.56
- Technical
- Relative Strength Index (RSI)
- SCNI 52.75
- LTRY 43.59
- Support Level
- SCNI $3.41
- LTRY $0.36
- Resistance Level
- SCNI $3.80
- LTRY $0.40
- Average True Range (ATR)
- SCNI 0.18
- LTRY 0.06
- MACD
- SCNI -0.00
- LTRY -0.02
- Stochastic Oscillator
- SCNI 36.42
- LTRY 2.73
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About LTRY Lottery.com Inc.
Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.